Concentration of Risk

DEXCOM INC

Medium

DXCM · Nasdaq · Surgical & Medical Instruments & Apparatus · CIK 0001093557

Latest filing: 10-K · 2026-02-12

Customer concentration

Significant Customers note · revenue dependency

High
Top exposure
55%
Customer A
+15.0pp YoY

Click a point to open the SEC source

FY23FY24FY250%15%30%45%60%

Geographic concentration

Segment reporting · geographic revenue

High
Top exposure
71.5%
United StatesNamed
Flat

Click a point to open the SEC source

FY23FY24FY250%20%40%60%80%

Supplier concentration

Risk Factors · supply chain dependency

Low
Dependency
Single source
Single sourceNamed
Qualitative disclosure — no % quantified (informational, not scored)
Flat
FY25

Qualitative dependency level by filing year.

Product concentration

ASC 275 · disclosed dependence on a specific product or service

Low
Top exposure
<10%
No disclosure detected
Flat

Credit concentration

ASC 825 · concentration of credit risk note

Low
Receivables
24%
Customer A
+6.0pp YoY

Click a point to open the SEC source

FY24FY250%6%12%18%24%
Featured on TerminalValue.io